Open Access Review Article Article ID: IJNNN-7-137

    Nanotechnology: A boon in cancer therapy: Review

    Sonia Sangwan* and Raman Seth

    In cancer, there is uncontrolled cell division, which results in invasion and metastasis. Carcinomas are a significant cause of mortality worldwide. Recently, radiotherapy and chemotherapy are the primary treatment measures that are being used to destroy cancer cells. However, these modalities kill normal cells of the body, along with the destruction of cancer cells. This non-specific action is harmful to the whole body, which results in the loss of hairs, anemia, and weakness in the body. Pathological features of tumors and their abnormal neo-angiogenesis also reduce the efficiency of conventional cancer treatment. Nanoparticles (NPs) have been considered outstanding cancer-targeting vehicles due to their small size, ability to load various drugs and large surface area, and increased absorption of conjugates. They are designed and developed to take advantage of a malignant tumor's morphology and characteristics, benefits of leaky tumor vasculature, specific cell surface antigen expression, and rapid proliferation. The recent nanoscale vehicles include liposomes, polymeric nanoparticles, magnetic nanoparticles, dendrimers, and nanoshells; lipid-based NPs have been used as conjugates.


    Published on: Jan 9, 2021 Pages: 1-6

    Full Text PDF Full Text HTML DOI: 10.17352/2455-3492.000037
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJNNN

    Help ? Google Reviews 11